Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use–an observational study of 46,506 Danish healthcare workers
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311260 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Aleksander Eiken und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Copenhagen University Hospital (Bispebjerg & Steno Diabetes Center Copenhagen), Copenhagen, Denmark. Hauptthemen laut MEDLINE: COVID-19, Health Personnel, SARS-CoV-2. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lundbeckfonden.
Abstract (Originalsprache)
It is not well investigated whether exposure to specific drug classes is associated with COVID-19. We investigated the risk of SARS-CoV-2 infection and severe COVID-19 among healthcare workers according to prescription drug use. We conducted an observational study among Danish healthcare workers. SARS-CoV-2 positivity was defined as a positive PCR/ELISA test throughout 2020 and severe COVID-19 as any above 48-hour hospitalization within 14 days after infection. Patient characteristics came from online surveys while data on SARS-CoV-2, drugs and hospitalizations came from Danish Health Registers. Infected individuals were matched with uninfected controls based on age, sex, and chronic diseases. Drug exposure was defined as any prescription redemption in the past six and one month(s) before infection for each drug class. Models assessing the risk of infection (conditional logistic regression) and severe COVID-19 (logistic regressions) versus drug usage were adjusted for BMI, smoking, alcohol, education, region, and patient contact when possible. We matched 5,710 SARS-CoV-2-infected cases with 57,021 controls. The odds of infection were reduced by calcium channel blocker (adjusted odds ratio (aOR) 0.81, 95% Confidence Interval (CI): 0.66–1.00) and vasoprotective drug (aOR 0.77, CI: 0.62–0.95) usage during the six months before infection compared to no usage. Exposure to antibacterials in the past month increased the odds of infection (aOR 1.27, CI: 1.09–1.48). Among infected participants, the odds of severe COVID-19 were higher with usage of almost any investigated drug, especially, diuretics (crude odds radio (OR) 4.82, CI:2.15–10.83), obstructive airway disease drugs (OR 4.49, CI: 2.49–8.08), and antibacterials (OR 2.74 CI:1.62–4.61). In conclusion, antibacterials were associated with more SARS-CoV-2 infections and calcium channel blockers with less. Once infected, users of prescription drugs had higher odds of developing severe COVID-19. These findings suggest a need for studies to clarify interactions between specific drug groups, behaviour, known risk factors, and disease susceptibility/severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Copenhagen University Hospital (Bispebjerg & Steno Diabetes Center Copenhagen), Copenhagen, Denmark.
- Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
- Center for Clinical Research and Prevention, Copenhagen University Hospital (Bispebjerg and Frederiksberg Hospital), Copenhagen, Denmark.
- Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Emergency Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
ORCID-Profile: Aleksander Eiken, Sofie Bliddal, Marie Villumsen, Rasmus B Hasselbach, Ram B Dessau, Christian Torp-Pedersen, Sisse B Ditlev, Mikkel Gybel-Brask, Ulla Feldt-Rasmussen
Förderung
- Lundbeckfonden
Zitieren
APA
Eiken, A., Bliddal, S., Villumsen, M., Iversen, K. K., Bundgaard, H., Hasselbach, R. B., Kristensen, J. H., Nielsen, P. B., Pries-Heje, M. M., Knudsen, A. D., Fogh, K., Norsk, J. B., Andersen, O., Fischer, T. K., Dessau, R. B., Ostrowski, S. R., Torp-Pedersen, C., Ditlev, S. B., Gybel-Brask, M., …, & Rungby, J. (2024). Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use–an observational study of 46,506 Danish healthcare workers. PLOS ONE. https://doi.org/10.1371/journal.pone.0311260
Vancouver
Eiken A, Bliddal S, Villumsen M, Iversen KK, Bundgaard H, Hasselbach RB, et al. Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use–an observational study of 46,506 Danish healthcare workers. PLOS ONE. 2024. doi:10.1371/journal.pone.0311260
BibTeX
@article{Eiken2024,
author = {Eiken, Aleksander and Bliddal, Sofie and Villumsen, Marie and Iversen, Kasper K and Bundgaard, Henning and Hasselbach, Rasmus B and Kristensen, Jonas H and Nielsen, Pernille B and Pries-Heje, Mia M and Knudsen, Andreas D and Fogh, Kamille and Norsk, Jakob B and Andersen, Ove and Fischer, Thea K and Dessau, Ram B and Ostrowski, Sisse R and Torp-Pedersen, Christian and Ditlev, Sisse B and Gybel-Brask, Mikkel and Sørensen, Erik and Harritshøj, Lene H and Folke, Fredrik and Benfield, Thomas and Engsig, Frederik N and Poulsen, Henrik E and Ullum, Henrik and Feldt-Rasmussen, Ulla and Nielsen, Susanne D and Rungby, Jørgen},
title = {Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use–an observational study of 46,506 Danish healthcare workers},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311260}
}
EUVIMED